Publikationen

2008:

  • Stettler C, Allemann S, Wandel S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabaté M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, De Carlo M, Erglis A, Chechi T, Ortolani P, Schalij MJ, Diem P, Meier B, Windecker S, Jüni P. Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis. BMJ. 337:668-81, 2008.
  • Califf RM, Boolell M, Haffner SM, Bethel MA, McMurray J, Duggal A, Holman RR; NAVIGATOR Study Group. Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial. Am Heart J. 156:623-32, 2008.
  • Billinger M, Beutler J, Taghetchian KR, Remondino A, Wenaweser P, Cook S, Togni M, Seiler C, Stettler C, Eberli FR, Lüscher TF, Wandel S, Jüni P, Meier B, Windecker S. Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients. Eur Heart J. 29:718-25, 2008.
  • Sahli R, Christ E. Schwangerschaft während aktiver Akromegalie. Dtsch Med Wochenschr. 133:2328-31, 2008.
  • Stolinski M, Alam S, Jackson NC, Shojaee-Moradie F, Pentecost C, Jefferson W, Christ ER, Jones RH, Umpleby AM. Effect of 6-month supervised exercise on low-density lipoprotein apolipoprotein B kinetics in patients with type 2 diabetes mellitus. Metabolism. 57:1608-14, 2008.
  • Rizzo M, Christ ER, Rini GB, Spinas GA, Berneis K. The differential effects of thiazolidindiones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance? Expert Opin Pharmacother. 2008 Sep;9(13):2295-303. Review.
  • Wild D, Mäcke H, Christ E, Gloor B, Reubi JC. Glucagon-like peptide 1-receptor scans to localize occult insulinomas. N Engl J Med. 359:766-8, 2008.
  • Jenni S, Oetliker C, Allemann S, Ith M, Tappy L, Wuerth S, Egger A, Boesch C, Schneiter P, Diem P, Christ E, Stettler C. Fuel metabolism during exercise in euglycaemia and hyperglycaemia in patients with type 1 diabetes mellitus - a prospective single-blinded randomised crossover trial. Diabetologia 51:1457-65, 2008.
  • Stettler C, Stahl M, Allemann S, Diem P, Schmidlin K, Zwahlen M, Riesen W, Keller U, Christ E: Association of 1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients. Diabetes Care 31:1534-5, 2008
  • Trepp R, Flück M, Stettler C, Boesch C, Ith M, Kreis R, Hoppeler H, Howald H, Schmid JP, Diem P, Christ ER: Effect of GH on human skeletal muscle lipid metabolism in GH deficiency. Am J Physiol Endocrinol Metab E1127-34, 2008.
  • Wustmann K, Kucera JP, Zanchi A, Burow A, Stuber T, Chappuis B, Diem P, Delacrétaz E: Activation of electrical triggers of atrial fibrillation in hyperthyroidism. J Clin Endocrinol Metab 93:2104-8, 2008.
  • Berneis K, Rizzo M, Stettler C, Chappuis B, Braun M, Diem P, Christ ER: Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial low-density lipoprotein size and subclasses in patients with Type 2 diabetes. Expert Opin Pharmacother 9:343-9, 2008.
  • Fischli S, Jenni S, Allemann S, Zwahlen M, Diem P, Christ ER, Stettler C: Dehydroepiandrosterone sulfate in the assessment of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab 93:539-42, 2008.

2007

  • Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabaté M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS, Nordmann AJ, Diem P, Meier B, Zwahlen M, Reichenbach S, Trelle S, Windecker S, Jüni P. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet  370: 937-948, 2007.
  • Scheidegger U, Allemann S, Scheidegger K, Diem P:  Continuous subcutaneous insulin infusion therapy: effects on quality of life. Swiss Med Wkly 137:476–482, 2007.
  • Chappuis B, Braun M, Stettler C, Allemann S, Diem P, Lumb PJ, Wierzbicki AS, James R, Christ ER: Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study. Diabetes Metab Res Rev. 23:392-9, 2007.
  • Stettler C, Bearth A, Allemann S, Zwahlen M, Zanchin L, Deplazes M, Christ ER, Teuscher A, Diem P: QT(c) interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: a 23-year follow-up. Diabetologia 50:186-94, 2007.
  • Rizzo M, Trepp R, Berneis K, Christ ER. Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy. Eur J Endocrinol. 156:361-7, 2007.
  • Laederach-Hofmann, K., Rohrer-Gübeli, R., Messerli-Buergy, N., Meyer, K. Comprehensive Rehabilitation in Chronic Heart Failure - Better Psycho-Emotional Status related to Quality of Life, Brain Natriuretic Peptide Levels, and Clinical Severity of Disease. Clin Invest Med. 30:100-8, 2007.
  • Chappuis B, Braun M, Stettler C, Allemann S, Diem P, Lumb PJ, Wierzbicki AS, James R, Christ ER: Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study. Diabetes Metab Res Rev. 2007 Jan 8; [Epub ahead of print].

2006:

  • Allemann S, Diem P, Egger M, Christ ER, Stettler C:  Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus: meta-analysis of randomised controlled trials. Curr Med Res Opin 22:617-23, 2006.
  • Christ ER, Zehnder M, Boesch C, Trepp R, Mullis PE, Diem P, Décombaz J: The effect of increased lipid intake on hormonal responses during aerobic exercise in endurance-trained:  The effect of increased lipid intake on hormonal responses during aerobic exercise in endurance-trained men.  Eur J Endocrinol 154:397-403, 2006.
  • Stettler C, Allemann S, Egger M, Windecker S, Meier B, Diem P: Efficacy of drug eluting stents in patients with and without diabetes mellitus: Indirect comparison of randomised controlled trials. Heart 92:650-7, 2006.
  • Stettler C, Jenni S, Allemann S, Steiner R, Hoppeler H, Trepp R, Christ ER, Zwahlen M, Diem P:  Exercise capacity in patients with type 1 diabetes mellitus under euglycaemic and hyperglycaemic conditions. Diabetes Metab Res Rev. 22:300-6, 2006.
  • Stettler C, Allemann S, Jüni P, Cull CA, Holman RR, Egger M, Krähenbühl S, Diem P: Glycemic control and macrovascular disease in type 1 and 2 diabetes mellitus: Meta-analysis of randomized trials. Am Heart J 152:27-38, 2006.
  • Wille T, Müller B, Noth D, Bürgi U, Diem P:  Langzeitverlauf nach thyreostatischer Therapie bei Basedow-Hyperthyreose.  Schw Rundschau Med (Praxis) 95:1121-1127, 2006.
  • Zehnder M, Christ ER, Ith M, Acheson KJ, Pouteau E, Kreis R, Trepp R, Diem P, Boesch C, Decombaz J: IMCL stores increase markedly in athletes after 1.5d lipid supplementation and are utilized during exercise in proportion to their content. Eur J Appl Physiol 98:341-54, 2006.
  • Stettler C, Suter Y, Allemann S, Zwahlen M, Christ ER, Diem P: Apolipoprotein B as a long-term predictor of mortality in type 1 diabetes mellitus: a 15-year follow up. J Intern Med 260:272-80, 2006.
  • Jensen RT, Rindi G, Arnold R, Lopes JM, Brandi ML, Bechstein WO, Christ E, Taal BG, Knigge U, Ahlman H, Kwekkeboom DJ, O'Toole D; Frascati Consensus Conference; European Neuroendocrine Tumor Society: Well-differentiated duodenal tumor/carcinoma (excluding gastrinomas). Neuroendocrinology. 84:165-72, 2006.

2005:

  • Trepp R, Everts R, Stettler C, Fischli S, Allemann S, Webb SM, Christ ER: Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the Acromegaly Quality of Life Questionnaire (AcroQoL). Clin Endocrinol (Oxf). 63:103-10, 2005.
  • Beer KT, Krause KB, Zuercher T, Stanga Z:  Early percutaneous endoscopic gastrostomy insertion maintains nutritional state in patients with aerodigestive tract cancer. Nutr Cancer. 52:29-34, 2005.
  • Trepp R, Stettler C, Zwahlen M, Seiler R, Diem P, Christ ER: Treatment outcomes and mortality of 94 patients with acromegaly. Acta Neurochir (Wien). 147:243-51, 2005.
  • Sahli R, Diem P, Christ ER: Endogener Hypercortisolismus und immunologisch vermittelte Krankheiten: drei Fälle. Dtsch Med Wochenschr. 130:2316-8, 2005.
  • Solca C, Stanga Z, Pandit B, Diem P, Greeve J, Patel SB: Sitosterolaemia in Switzerland: molecular genetics links the US Amish-Mennonites to their European roots. Clin Genet. 68:174-8, 2005.
  • Mueller B, Fajfr R, Diem P: Pancreatic elastase-1 in stools, a marker of exocrine pancreas function, correlates with both residual beta-cell secretion and metabolic control in type 1 diabetic subjects: response to Cavalot et al. Diabetes Care. 28:2809-10, 2005.
  • Frick C, Kosel M, Schlaepfer TE, Stanga Z, Hasdemir MG: Incident mania during therapy with vagus nerve stimulation. J ECT 21:197, 2005.
  • Diem P: "Typ 2 - Denk 3!" Artikelserie zum Diabetes mellitus. Schweiz Med Forum 5:963, 2005.
  • Schwab S, Suter S, Müller B, Diem P: Orale Antidiabetika - Substanzen, Indikation, Perspektiven. Schweiz Med Forum 5:993-999, 2005.
    Diem P: HbA1c revisited. Schweiz Med Forum 5:1126-1127, 2005.